Literature DB >> 34563643

Amplification of neurotoxic HTTex1 assemblies in human neurons.

Anjalika Chongtham1, J Mario Isas2, Nitin K Pandey2, Anoop Rawat2, Jung Hyun Yoo1, Tara Mastro1, Mary B Kennedy1, Ralf Langen2, Ali Khoshnan3.   

Abstract

Huntington's disease (HD) is a genetically inherited neurodegenerative disorder caused by expansion of a polyglutamine (polyQ) repeat in the exon-1 of huntingtin protein (HTT). The expanded polyQ enhances the amyloidogenic propensity of HTT exon 1 (HTTex1), which forms a heterogeneous mixture of assemblies with a broad neurotoxicity spectrum. While predominantly intracellular, monomeric and aggregated mutant HTT species are also present in the cerebrospinal fluids of HD patients, however, their biological properties are not well understood. To explore the role of extracellular mutant HTT in aggregation and toxicity, we investigated the uptake and amplification of recombinant HTTex1 assemblies in cell culture models. We find that small HTTex1 fibrils preferentially enter human neurons and trigger the amplification of neurotoxic assemblies; astrocytes or epithelial cells are not permissive. The amplification of HTTex1 in neurons depletes endogenous HTT protein with non-pathogenic polyQ repeat, activates apoptotic caspase-3 pathway and induces nuclear fragmentation. Using a panel of novel monoclonal antibodies and genetic mutation, we identified epitopes within the N-terminal 17 amino acids and proline-rich domain of HTTex1 to be critical in neural uptake and amplification. Synaptosome preparations from the brain homogenates of HD mice also contain mutant HTT species, which enter neurons and behave similar to small recombinant HTTex1 fibrils. These studies suggest that amyloidogenic extracellular mutant HTTex1 assemblies may preferentially enter neurons, propagate and promote neurodegeneration. Published by Elsevier Inc.

Entities:  

Keywords:  Huntingtin; Huntingtin exon1; Huntington's disease; Neurotoxicity; Seeding

Mesh:

Substances:

Year:  2021        PMID: 34563643      PMCID: PMC8943833          DOI: 10.1016/j.nbd.2021.105517

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

1.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

2.  The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.

Authors:  Nitin K Pandey; J Mario Isas; Anoop Rawat; Rachel V Lee; Jennifer Langen; Priyatama Pandey; Ralf Langen
Journal:  J Biol Chem       Date:  2017-12-27       Impact factor: 5.157

3.  Structure of Membrane-Bound Huntingtin Exon 1 Reveals Membrane Interaction and Aggregation Mechanisms.

Authors:  Meixin Tao; Nitin K Pandey; Ryan Barnes; Songi Han; Ralf Langen
Journal:  Structure       Date:  2019-08-26       Impact factor: 5.006

4.  Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.

Authors:  Y J Kim; Y Yi; E Sapp; Y Wang; B Cuiffo; K B Kegel; Z H Qin; N Aronin; M DiFiglia
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

5.  Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms.

Authors:  Maria Masnata; Giacomo Sciacca; Alexander Maxan; Luc Bousset; Hélèna L Denis; Florian Lauruol; Linda David; Martine Saint-Pierre; Jeffrey H Kordower; Ronald Melki; Melanie Alpaugh; Francesca Cicchetti
Journal:  Acta Neuropathol       Date:  2019-02-20       Impact factor: 17.088

6.  A sex difference in the response of the rodent postsynaptic density to synGAP haploinsufficiency.

Authors:  Tara L Mastro; Anthony Preza; Shinjini Basu; Sumantra Chattarji; Sally M Till; Peter C Kind; Mary B Kennedy
Journal:  Elife       Date:  2020-01-15       Impact factor: 8.140

7.  Targeting Huntingtin Expression in Patients with Huntington's Disease.

Authors:  Sarah J Tabrizi; Blair R Leavitt; G Bernhard Landwehrmeyer; Edward J Wild; Carsten Saft; Roger A Barker; Nick F Blair; David Craufurd; Josef Priller; Hugh Rickards; Anne Rosser; Holly B Kordasiewicz; Christian Czech; Eric E Swayze; Daniel A Norris; Tiffany Baumann; Irene Gerlach; Scott A Schobel; Erika Paz; Anne V Smith; C Frank Bennett; Roger M Lane
Journal:  N Engl J Med       Date:  2019-05-06       Impact factor: 91.245

8.  Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted.

Authors:  J Mario Isas; Nitin K Pandey; Hui Xu; Kazuki Teranishi; Alan K Okada; Ellisa K Fultz; Anoop Rawat; Anise Applebaum; Franziska Meier; Jeannie Chen; Ralf Langen; Ansgar B Siemer
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

9.  Elevated IKKα accelerates the differentiation of human neuronal progenitor cells and induces MeCP2-dependent BDNF expression.

Authors:  Ali Khoshnan; Paul H Patterson
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  4 in total

Review 1.  Ellagic Acid: A Dietary-Derived Phenolic Compound for Drug Discovery in Mild Cognitive Impairment.

Authors:  Wenjun Wang; Shaohui Wang; Yue Liu; Xiaobo Wang; Jia Nie; Xianli Meng; Yi Zhang
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

Review 2.  Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.

Authors:  Srinivasa Subramaniam
Journal:  J Huntingtons Dis       Date:  2022

3.  Gut Bacteria Regulate the Pathogenesis of Huntington's Disease in Drosophila Model.

Authors:  Anjalika Chongtham; Jung Hyun Yoo; Theodore M Chin; Ngozi D Akingbesote; Ainul Huda; J Lawrence Marsh; Ali Khoshnan
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

Review 4.  Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease.

Authors:  Kirby M Donnelly; Cevannah M Coleman; Madison L Fuller; Victoria L Reed; Dayna Smerina; David S Tomlinson; Margaret M Panning Pearce
Journal:  Front Neurosci       Date:  2022-08-24       Impact factor: 5.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.